Frequent early cognitive impairment in both pediatric MS and MOGAD
Michiel Simon Jan Buijze, Sandy Molenaar, Rosa Verkerk, Maud Alida Quist, Willemijn Marije Carolien van der Vlugt, Rinze Frederik NeuteboomBackground:
Studies on early cognitive impairment (CI) in pediatric multiple sclerosis (MS) are heterogeneous and data on pediatric myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) are scarce.
Objectives:
To evaluate early cognitive dysfunction in both diseases and delineate disease-specific neurocognitive profiles.
Methods:
A cross-sectional study of children with MS and MOGAD assessed neurocognition within 2 years after disease onset using a comprehensive test battery. Test results were converted to
Results:
Sixty-seven participants were analyzed (MS
Conclusion:
In both pediatric MS and MOGAD, early CI is prevalent with difficulties in complex attention. Visuospatial cognition appears to be an additional vulnerable area for children with MS.